Erste Asset Management’s Intellia Therapeutics NTLA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $814K | Buy |
85,100
+63,000
| +285% | +$602K | 0.01% | 542 |
|
|
2025
Q1 | $178K | Hold |
22,100
| – | – | ﹤0.01% | 479 |
|
|
2024
Q4 | $265K | Hold |
22,100
| – | – | ﹤0.01% | 477 |
|
|
2024
Q3 | $464K | Hold |
22,100
| – | – | 0.01% | 442 |
|
|
2024
Q2 | $512K | Hold |
22,100
| – | – | 0.01% | 418 |
|
|
2024
Q1 | $597K | Hold |
22,100
| – | – | 0.01% | 409 |
|
|
2023
Q4 | $702K | Hold |
22,100
| – | – | 0.01% | 405 |
|
|
2023
Q3 | $702K | Hold |
22,100
| – | – | 0.01% | 375 |
|
|
2023
Q2 | $904K | Hold |
22,100
| – | – | 0.02% | 371 |
|
|
2023
Q1 | $796K | Hold |
22,100
| – | – | 0.02% | 391 |
|
|
2022
Q4 | $780K | Sell |
22,100
-45
| -0.2% | -$1.59K | 0.02% | 385 |
|
|
2022
Q3 | $1.22M | Hold |
22,145
| – | – | 0.03% | 329 |
|
|
2022
Q2 | $1.16M | Buy |
22,145
+5,800
| +35% | +$304K | 0.03% | 338 |
|
|
2022
Q1 | $1.18M | Buy |
16,345
+6,500
| +66% | +$469K | 0.02% | 341 |
|
|
2021
Q4 | $1.17M | Buy |
9,845
+45
| +0.5% | +$5.33K | 0.02% | 343 |
|
|
2021
Q3 | $1.35M | Hold |
9,800
| – | – | 0.03% | 310 |
|
|
2021
Q2 | $1.49M | Hold |
9,800
| – | – | 0.03% | 318 |
|
|
2021
Q1 | $708K | Sell |
9,800
-7,800
| -44% | -$563K | 0.02% | 358 |
|
|
2020
Q4 | $961K | Buy |
+17,600
| New | +$961K | 0.03% | 340 |
|
|
2019
Q1 | – | Sell |
-14,000
| Closed | -$172K | – | 748 |
|
|
2018
Q4 | $172K | Buy |
+14,000
| New | +$172K | 0.01% | 377 |
|